Strong Eczema Response to JAK Inhibitor
MedPage Today SAN DIEGO — Patients with moderate or severe atopic dermatitis (AD) had as much as 74% improvement in disease status with the oral Janus kinase (JAK) inhibitor upadacitinib, a randomized trial showed. After 16 weeks, patients randomized to one of … |
Tag Archives: Strong
5 Keys to Strong Business Relationships
Looking for how to build strong business relationships? Here’s a checklist to help you connect more effectively with current and potential partners.
Dermatology Times – Dermatology